Preston, CT, United States of America

Laurie A Tylaska



 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovative Contributions of Laurie A Tylaska

Introduction

Laurie A Tylaska is a prominent inventor based in Preston, Connecticut, known for her significant contributions to the field of biotechnology. With a total of two patents to her name, she has played a vital role in advancing medical research and therapeutic applications, particularly in the area of antibodies that target CCR2.

Latest Patents

Laurie Tylaska's latest patents focus on nucleic acids encoding antibodies to CCR2. These patents provide valuable insights into human antibodies and their antigen-binding portions that specifically target CCR2. They highlight the potential of these antibodies to inhibit CCR2 function, which is critical in various medical conditions. Her patents detail isolated heavy and light chains derived from these antibodies, as well as nucleic acid molecules encoding them. The documented methods not only cover the production and application of anti-CCR2 antibodies but also explore gene therapy methods utilizing the nucleic acid molecules. Additionally, her innovations contribute to the development of diagnostic and therapeutic compositions, broadening the scope of treatment options available for various diseases.

Career Highlights

Laurie Tylaska has established a notable career, notably working with esteemed organizations such as Pfizer Corporation and Amgen Fremont Inc. Her involvement in these leading companies has allowed her to leverage her expertise and drive innovation within the biopharmaceutical industry.

Collaborations

Throughout her career, Laurie has collaborated with several notable colleagues, including Ronald P Gladue and Bradley T Keller. These partnerships have not only fostered innovation but have also facilitated a productive exchange of ideas and knowledge in the biotechnology field.

Conclusion

Laurie A Tylaska's innovative spirit and dedication to enhancing scientific understanding through her patents demonstrate her invaluable contributions to the biotechnology sector. With her focus on antibodies and gene therapy methods, she remains at the forefront of medical innovation, significantly impacting therapeutic strategies for treating diseases related to CCR2.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…